Amylyx Pharmaceuticals, Inc. AMLX Increase Decrease In Deposits And Other Assets
Increase Decrease In Deposits And Other Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amlx:IncreaseDecreaseInDepositsAndOtherAssets.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s increase decrease in deposits and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s increase decrease in deposits and other assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported increase decrease in deposits and other assets of $494K in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s increase decrease in deposits and other assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s increase decrease in deposits and other assets increased by 391.9% year-over-year, from -$169.25K to $494K.
- What does increase decrease in deposits and other assets mean?
- This captures the net change in cash deposits and miscellaneous assets that do not fall into standard working capital categories. Fluctuations often relate to security deposits for facilities or other long-term contractual obligations. It provides insight into the company's non-operating cash commitments and asset management.